Improvements in post-surgical mortality for esophageal cancer
Although esophageal cancer remains one of the most deadly cancers, this Swedish population-based study from the Karolinska Institutet documents
Real-world experience with capsule sponge test
This large prospective observational study evaluated the potential usefulness of the Capsule Sponge (CS) test – a non-invasive method of
Circulating tumor DNA and recurrence of esophagogastric cancer
Persons with esophagogastric adenocarcinoma who undergo neoadjuvant therapy and curative-intent surgery are unfortunately still at risk for recurrence even
Cost-effectiveness analysis of Barrett's screening
From South Australia's Flinders University, Dr. Aoki and colleagues report on a cost-effectiveness analysis of various screening
Liquid biopsy to diagnose esophageal adenocarcinoma
This impressive multicenter study by Miyoshi et al. introduces a new diagnostic tool named EMERALD, which is a six-circulating
Neoplastic progression in young Barrett's patients
Esophageal adenocarcinoma is quite rare among persons younger than 40 years, but the consequences of the disease, including years of
Diagnosis and management of GERD
While most adults occasionally experience symptoms of gastroesophageal reflux, such as heartburn and regurgitation, approximately 20% (30 million people in
Ethics of screening based on race/ethnicity
This article explores some of the ethical implications of using race and ethnicity for cancer screening, using esophageal adenocarcinoma and
Tension between risk-based and patient-centered esophageal cancer screening
This interesting and thoughtful paper by Dr. Elspeth Davies at the University of Cambridge investigates the use of the capsule
Eradication therapy for Barrett's
An evidence-based compendium of recommended treatments